Mazzo David J 4
4 · LISATA THERAPEUTICS, INC. · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Mazzo David J
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2025-01-10$3.73/sh−3,106$11,585→ 264,690 total - Award
Stock Option (Right to Buy)
2025-01-09+40,000→ 40,000 totalExercise: $3.80From: 2025-01-09Exp: 2035-01-09→ Common Stock (40,000 underlying) - Tax Payment
Common Stock
2025-01-09$3.80/sh−9,414$35,773→ 285,738 total - Award
Common Stock
2025-01-09+81,000→ 295,152 total - Tax Payment
Common Stock
2025-01-09$3.80/sh−10,925$41,515→ 274,813 total - Tax Payment
Common Stock
2025-01-09$3.80/sh−7,017$26,665→ 267,796 total
Footnotes (5)
- [F1]Represents 81,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 129,433 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]Includes 122,750 unvested restricted stock.
- [F5]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.